ANAPEINE Side Effects

6690355-X | Delayed Recovery From Anaesthesia
on Apr 16, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with epidural anaesthesia, epidural test dose and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: delayed recovery from anaesthesia. Anapeine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), MORPHINE (View Morphine Review and Morphine Label ).

6652902-3 | Hypoaesthesia
Patient was taking Anapeine (View Usage). Patient had the following side effects: hypoaesthesia on Mar 19, 2010 from JAPAN Additional patient health information: Female patient , 35 years of age, weighting 99.21 lb, was diagnosed with epidural anaesthesia and. Anapeine dosage: 150ml. During the same period patient was treated with FENTANYL (10ml) (View Fentanyl Review and Fentanyl Label ), DROLEPTAN (2ml) (View Droleptan Review and Droleptan Label ), SEISHOKU (38ml) (View Seishoku Review and Seishoku Label ). Patient was hospitalized.

6645625-8 | Hepatic Function Abnormal
Adverse event was reported on Mar 16, 2010 by a Male patient taking Anapeine (View Usage) (Dosage: 0.2% 5ml/h) was diagnosed with pneumonia (What is pneumonia?), prophylaxis, decubitus ulcer, gastrointestinal disorder, anaesthesia procedure and. Location: JAPAN , weighting 132.3 lb, After Anapeine was administered, patient had the following side effects: hepatic function abnormal. During the same period patient was treated with DALACIN P (View Dalacin-p Review and Dalacin-p Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), FIBLAST (View Fiblast Review and Fiblast Label ), DORIPENEM MONOHYDRATE (View Doripenem Monohydrate Review and Doripenem Monohydrate Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MUSCULAX (View Musculax Review and Musculax Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

6627643-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatic Function Abnormal
on Mar 03, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with epidural anaesthesia and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Anapeine dosage: . During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), DALACIN (View Dalacin Review and Dalacin Label ). Patient was hospitalized.


6609427-0 | Monoplegia
on Feb 22, 2010 Female patient from JAPAN , 35 years of age, was diagnosed with epidural anaesthesia and was treated with Anapeine (View Usage). Patient had the following side effects: monoplegia. Anapeine dosage: 0.2% Per Day.. Patient was hospitalized.

6569549-X | Blood Pressure Decreased, Monoplegia, Pyrexia, Spinal Cord Infarction
Patient was taking Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: blood pressure decreased, monoplegia, pyrexia, spinal cord infarction on Jan 28, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with epidural anaesthesia, antipyresis and. Anapeine dosage: . During the same period patient was treated with ANTIPYRETICS, ANALGESICS AND ANTI INFLAMMATORY AGENTS (View Antipyretics, Analgesics And Anti-inflammatory Agents Review and Antipyretics, Analgesics And Anti-inflammatory Agents Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6565316-1 | Cardiac Arrest, Respiratory Arrest
Adverse event was reported on Jan 29, 2010 by a Male patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with nerve block, angina pectoris, hypertension, diabetes mellitus, gastrointestinal disorder and. Location: JAPAN , 60 years of age, weighting 92.59 lb, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. During the same period patient was treated with XYLOCAINE (20ml 5ml) (View Xylocaine Review and Xylocaine Label ), FENTANYL (25mcg + 50mcg + 25mcg) (View Fentanyl Review and Fentanyl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MICARDIS (View Micardis Review and Micardis Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (2 Iu On Irregular Basis) (View Novorapid Review and Novorapid Label ), LAC B (View Lac-b Review and Lac-b Label ).

6546378-4 | Torsade De Pointes
on Jan 20, 2010 Female patient from JAPAN , 89 years of age, weighting 99.21 lb, was diagnosed with epidural anaesthesia, induction of anaesthesia, dementia (What is dementia?), epidural test dose and was treated with Anapeine (View Usage). Patient had the following side effects: torsade de pointes. Anapeine dosage: With Diluted (by Twenty Thousand-fold) Epinephrine. During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), XYLOCAINE (2ml) (View Xylocaine Review and Xylocaine Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), PROPOFOL (View Propofol Review and Propofol Label ), CEFAMEZIN ALPHA (View Cefamezin Alpha Review and Cefamezin Alpha Label ).

6446559-4 | Cauda Equina Syndrome
on Nov 11, 2009 Male patient from JAPAN , 49 years of age, weighting 141.1 lb, was diagnosed with epidural test dose, induction of anaesthesia, maintenance of anaesthesia, hypertension and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: cauda equina syndrome. Anapeine dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), SEISHOKU (View Seishoku Review and Seishoku Label ), PROPOFOL (View Propofol Review and Propofol Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NORVASC (View Norvasc Review and Norvasc Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), CEZ (View Cez Review and Cez Label ).

6428206-0 | Cauda Equina Syndrome
Patient was taking Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: cauda equina syndrome on Oct 28, 2009 from JAPAN Additional patient health information: Male patient , 72 years of age, weighting 114.6 lb, was diagnosed with epidural anaesthesia and. Anapeine dosage: . During the same period patient was treated with CARBOCAIN (1.5 % 10 Ml X2 At 14.30 And 14.45) (View Carbocain Review and Carbocain Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), DORMICUM (View Dormicum Review and Dormicum Label ). Patient was hospitalized.

6396526-4 | Sensorimotor Disorder
Adverse event was reported on Oct 02, 2009 by a Female patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, epidural test dose and. Location: JAPAN , 27 years of age, weighting 90.39 lb, Patient had the following side effects: sensorimotor disorder. During the same period patient was treated with XYLOCAINE W/ EPINEPHRINE (View Xylocaine W/ Epinephrine Review and Xylocaine W/ Epinephrine Label ).

6379867-6 | Altered State Of Consciousness, Blood Ph Increased, Blood Pressure Decreased, Clonic Convulsion, Heart Rate Decreased, Loss Of Consciousness, Oxygen Saturation Decreased, Pain, Pallor
on Sep 24, 2009 Female patient from JAPAN , 40 years of age, weighting 88.18 lb, was diagnosed with nerve block, induction and maintenance of anaesthesia, induction of anaesthesia, anaesthesia reversal, antibiotic prophylaxis and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: altered state of consciousness, blood ph increased, blood pressure decreased, clonic convulsion, heart rate decreased, loss of consciousness, oxygen saturation decreased, pain (What is pain?), pallor. Anapeine dosage: . During the same period patient was treated with SEISHOKU (View Seishoku Review and Seishoku Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ULTIVA (View Ultiva Review and Ultiva Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NEOSTIGMINE METHYLSULFATE (View Neostigmine Methylsulfate Review and Neostigmine Methylsulfate Label ), CEZ (View Cez Review and Cez Label ).

6371862-6 | Altered State Of Consciousness, Clonic Convulsion
on Sep 15, 2009 Female patient from JAPAN , 40 years of age, weighting 88.18 lb, was diagnosed with nerve block, induction and maintenance of anaesthesia, induction of anaesthesia, anaesthesia reversal, antibiotic prophylaxis and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, clonic convulsion. Anapeine dosage: . During the same period patient was treated with SEISHOKU (View Seishoku Review and Seishoku Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ULTIVA (View Ultiva Review and Ultiva Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NEOSTIGMINE METHYLSULFATE (View Neostigmine Methylsulfate Review and Neostigmine Methylsulfate Label ), CEZ (View Cez Review and Cez Label ).

6313029-3 | Peroneal Nerve Palsy
Patient was taking Anapeine (View Usage). Patient had the following side effects: peroneal nerve palsy on Aug 10, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 105.8 lb, was diagnosed with pain management, type 2 diabetes mellitus, hypertension and. Anapeine dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), DIOVAN (View Diovan Review and Diovan Label ).

6299183-0 | Peroneal Nerve Palsy
Adverse event was reported on Aug 03, 2009 by a Male patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with pain management and. Location: JAPAN , 73 years of age, weighting 105.8 lb, After Anapeine was administered, patient had the following side effects: peroneal nerve palsy.

6296142-9 | Phrenic Nerve Paralysis
on Jul 27, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with nerve block and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: phrenic nerve paralysis. Anapeine dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

6294735-6 | Delayed Recovery From Anaesthesia
on Jul 23, 2009 Female patient from JAPAN , 88 years of age, weighting 68.34 lb, was diagnosed with nerve block, hypertension, atrial fibrillation (What is atrial fibrillation?), postoperative analgesia and was treated with Anapeine (View Usage). Patient had the following side effects: delayed recovery from anaesthesia. Anapeine dosage: . During the same period patient was treated with ULTIVA (View Ultiva Review and Ultiva Label ), PROPOFOL (View Propofol Review and Propofol Label ), ESLAX (View Eslax Review and Eslax Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERDIPINE (View Perdipine Review and Perdipine Label ), ONOACT (Started At 2mcg/kg/min, Subsequently Increased To 5mcg/kg/min) (View Onoact Review and Onoact Label ), FENTANYL (30mcg/hr) (View Fentanyl Review and Fentanyl Label ).

6291781-3 | Cauda Equina Syndrome
Patient was taking Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: cauda equina syndrome on Jul 22, 2009 from JAPAN Additional patient health information: Male patient , 49 years of age, weighting 141.1 lb, was diagnosed with analgesia, epidural test dose, induction of anaesthesia, maintenance of anaesthesia, hypertension and. Anapeine dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), SEISHOKU (View Seishoku Review and Seishoku Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), PROPOFOL (View Propofol Review and Propofol Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NORVASC (View Norvasc Review and Norvasc Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), CEZ (View Cez Review and Cez Label ).

6291618-2 | Peroneal Nerve Palsy
Adverse event was reported on Jul 22, 2009 by a Male patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with pain management and. Location: JAPAN , 73 years of age, weighting 105.8 lb, Patient experienced the following unwanted or unexpected effects: peroneal nerve palsy.

6291471-7 | Phrenic Nerve Paralysis
on Jul 22, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with nerve block and was treated with Anapeine (View Usage). Patient had the following side effects: phrenic nerve paralysis. Anapeine dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

6278215-X | Feeling Cold, Femoral Nerve Palsy, Illusion, Movement Disorder, Nerve Root Compression, Nerve Root Injury, Nervous System Disorder, Pain
on Jul 14, 2009 Female patient from JAPAN , 30 years of age, weighting 112.4 lb, was diagnosed with analgesia, epidural anaesthesia, spinal anaesthesia, sedation, fluid replacement and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: feeling cold, femoral nerve palsy, illusion, movement disorder (What is movement disorder?), nerve root compression, nerve root injury, nervous system disorder, pain (What is pain?). Anapeine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), MARCAINE HYDROCHLORIDE PRESERVATIVE FREE (View Marcaine Hydrochloride Preservative Free Review and Marcaine Hydrochloride Preservative Free Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), SOSEGON (View Sosegon Review and Sosegon Label ), ATARAX (View Atarax Review and Atarax Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), SOLACET F (View Solacet F Review and Solacet F Label ).

6274236-1 | Altered State Of Consciousness
Patient was taking Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness on Jul 09, 2009 from JAPAN Additional patient health information: Female patient , 89 years of age, weighting 110.2 lb, was diagnosed with epidural anaesthesia, anaesthesia procedure and. Anapeine dosage: . During the same period patient was treated with LEPETAN (View Lepetan Review and Lepetan Label ), SOSEGON (View Sosegon Review and Sosegon Label ). Patient was hospitalized.

6266874-7 | Cauda Equina Syndrome
Adverse event was reported on Jul 02, 2009 by a Male patient taking Anapeine (View Usage) (Dosage: 4 Ml/h) was diagnosed with analgesia, hypertension, epidural test dose and. Location: JAPAN , 49 years of age, weighting 141.1 lb, Patient had the following side effects: cauda equina syndrome. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), CEZ (View Cez Review and Cez Label ), INOVAN (View Inovan Review and Inovan Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), HANP (View Hanp Review and Hanp Label ).

6243112-2 | Monoplegia, Peripheral Nerve Injury
on Jun 15, 2009 Male patient from JAPAN , 29 years of age, weighting 138.9 lb, was diagnosed with nerve block and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: monoplegia, peripheral nerve injury. Anapeine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), FENTANEST (View Fentanest Review and Fentanest Label ). Patient was hospitalized and became disabled.

6233983-8 | Grand Mal Convulsion
on Jun 10, 2009 Female patient from JAPAN , 74 years of age, weighting 163.1 lb, was diagnosed with nerve block, spinal anaesthesia and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion. Anapeine dosage: . During the same period patient was treated with BUPIVACAINE HYDROCHLORIDE (View Bupivacaine Hydrochloride Review and Bupivacaine Hydrochloride Label ).

6232965-X | Anorectal Disorder, Bladder Disorder
Patient was taking Anapeine (View Usage). Patient had the following side effects: anorectal disorder, bladder disorder on Jun 08, 2009 from JAPAN Additional patient health information: Male patient , 49 years of age, was diagnosed with epidural anaesthesia, analgesia, epidural test dose and. Anapeine dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ).

6173675-7 | Blood Pressure Increased, Heart Rate Increased
Adverse event was reported on Apr 21, 2009 by a Female patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with nerve block and. Location: JAPAN , 64 years of age, weighting 112.4 lb, After Anapeine was administered, patient had the following side effects: blood pressure increased, heart rate increased. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

6168151-1 | Sensorimotor Disorder
on Apr 17, 2009 Female patient from JAPAN , 27 years of age, weighting 90.39 lb, was diagnosed with epidural anaesthesia, analgesia, epidural test dose and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: sensorimotor disorder. Anapeine dosage: . During the same period patient was treated with XYLOCAINE W/ EPINEPHRINE (View Xylocaine W/ Epinephrine Review and Xylocaine W/ Epinephrine Label ).

6145974-6 | Blood Pressure Decreased, Muscular Weakness, Sensory Disturbance
on Mar 30, 2009 Female patient from JAPAN , 32 years of age, weighting 154.3 lb, was diagnosed with epidural anaesthesia, spinal anaesthesia, blood pressure decreased and was treated with Anapeine (View Usage). Patient had the following side effects: blood pressure decreased, muscular weakness, sensory disturbance. Anapeine dosage: Diluted By 0.2% And Administered At 7.5mg/day For 2 Days.. During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ), MORPHINE HYDROCHLORIDE (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), EPHEDRINE HYDROCHLORIDE (A Total Of 44 Mg (11 Times/day).) (View Ephedrine Hydrochloride Review and Ephedrine Hydrochloride Label ). Patient was hospitalized.

6125822-0 | Dysaesthesia, Muscular Weakness
Patient was taking Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: dysaesthesia, muscular weakness on Mar 12, 2009 from JAPAN Additional patient health information: Male patient , 40 years of age, weighting 165.3 lb, was diagnosed with postoperative analgesia, epidural anaesthesia and. Anapeine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), LEPETAN (View Lepetan Review and Lepetan Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ).

5360743-2 | Shock
Adverse event was reported on Jun 12, 2007 by a Male patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with anaesthesia, influenza immunisation and. Location: JAPAN , weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: shock. During the same period patient was treated with NEUROTROPIN (View Neurotropin Review and Neurotropin Label ), INFLUENZA HA VACCINE (View Influenza Ha Vaccine Review and Influenza Ha Vaccine Label ).

5353613-7 | Clonic Convulsion, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram T Wave Amplitude Increased, Sinus Tachycardia
on May 23, 2007 Male patient from JAPAN , 48 years of age, was diagnosed with nerve block and was treated with Anapeine (View Usage). Patient had the following side effects: clonic convulsion, electrocardiogram qrs complex prolonged, electrocardiogram t wave amplitude increased, sinus tachycardia. Anapeine dosage: .

5349662-5 | Clonic Convulsion, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram T Wave Amplitude Increased, Sinus Tachycardia
on May 23, 2007 Male patient from JAPAN , weighting 152.1 lb, was diagnosed with local anaesthesia, infiltration anaesthesia, fluid replacement and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: clonic convulsion, electrocardiogram qrs complex prolonged, electrocardiogram t wave amplitude increased, sinus tachycardia. Anapeine dosage: . During the same period patient was treated with CARBOCAIN (View Carbocain Review and Carbocain Label ), FENTANEST (View Fentanest Review and Fentanest Label ), VEEN F (View Veen-f Review and Veen-f Label ).

5345784-3 | Paralysis
Patient was taking Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: paralysis (What is paralysis?) on May 25, 2007 from JAPAN Additional patient health information: Male patient , weighting 123.9 lb, was diagnosed with epidural anaesthesia, pain (What is pain?), haemorrhage and. Anapeine dosage: . During the same period patient was treated with MARCAINE HYDROCHLORIDE PRESERVATIVE FREE (View Marcaine Hydrochloride Preservative Free Review and Marcaine Hydrochloride Preservative Free Label ), CARBOCAIN (View Carbocain Review and Carbocain Label ), PURSENNID (View Pursennid Review and Pursennid Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), ADONA (View Adona Review and Adona Label ).

5342330-5 | Clonic Convulsion, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram T Wave Amplitude Increased, Sinus Tachycardia
Adverse event was reported on May 23, 2007 by a Male patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with nerve block and. Location: JAPAN , 48 years of age, Patient had the following side effects: clonic convulsion, electrocardiogram qrs complex prolonged, electrocardiogram t wave amplitude increased, sinus tachycardia.

5322370-2 | Monoplegia, Pain In Extremity
on May 01, 2007 Male patient from JAPAN , 56 years of age, was diagnosed with epidural anaesthesia and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: monoplegia, pain in extremity. Anapeine dosage: . During the same period patient was treated with MARCAINE HYDROCHLORIDE PRESERVATIVE FREE (View Marcaine Hydrochloride Preservative Free Review and Marcaine Hydrochloride Preservative Free Label ), CARBOCAIN (View Carbocain Review and Carbocain Label ).

5312290-1 | Convulsion
on Apr 17, 2007 Male patient from JAPAN , weighting 110.2 lb, was diagnosed with nerve block and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Anapeine dosage: . During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ). Patient was hospitalized.

5307994-0 | Shock
Patient was taking Anapeine (View Usage). Patient had the following side effects: shock on Apr 20, 2007 from JAPAN Additional patient health information: Male patient , weighting 99.21 lb, was diagnosed with anaesthesia, influenza immunisation and. Anapeine dosage: . During the same period patient was treated with NEUROTROPIN (View Neurotropin Review and Neurotropin Label ), INFLUENZA HA VACCINE (View Influenza Ha Vaccine Review and Influenza Ha Vaccine Label ).

5307985-X | Arteriospasm Coronary
Adverse event was reported on Apr 18, 2007 by a Female patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, maintenance of anaesthesia, induction of anaesthesia and. Location: JAPAN , 70 years of age, weighting 101.4 lb, After Anapeine was administered, patient had the following side effects: arteriospasm coronary. During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

5262889-6 | Nerve Injury
on Nov 27, 2006 Female patient from JAPAN , weighting 116.8 lb, was diagnosed with epidural anaesthesia and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: nerve injury. Anapeine dosage: . During the same period patient was treated with CARBOCAIN (Test Dose) (View Carbocain Review and Carbocain Label ). Patient was hospitalized.

5235809-8 | Asthma, Blood Pressure Decreased, Left Ventricular Failure, Oxygen Saturation Decreased, Pulmonary Oedema, Stress Cardiomyopathy, Stridor
on Jan 31, 2007 Female patient from JAPAN , 76 years of age, was diagnosed with nerve block and was treated with Anapeine (View Usage). Patient had the following side effects: asthma (What is asthma?), blood pressure decreased, left ventricular failure, oxygen saturation decreased, pulmonary oedema, stress cardiomyopathy, stridor. Anapeine dosage: . During the same period patient was treated with CARBOCAIN (View Carbocain Review and Carbocain Label ), ANABOLIC STEROIDS AND PREPARATIONS (View Anabolic Steroids And Preparations Review and Anabolic Steroids And Preparations Label ), BRONCHODILATORS (View Bronchodilators Review and Bronchodilators Label ).

5226473-2 | Shock
Patient was taking Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: shock on Jan 26, 2007 from JAPAN Additional patient health information: Male patient , 80 years of age, . Anapeine dosage: . During the same period patient was treated with INFLUENZA HA VACCINE (View Influenza Ha Vaccine Review and Influenza Ha Vaccine Label ).

5226260-5 | Convulsion, Tachycardia
Adverse event was reported on Jan 24, 2007 by a Female patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with local anaesthesia, hypertension, dialysis (What is dialysis?), induction of anaesthesia, maintenance of anaesthesia and. Location: JAPAN , weighting 83.78 lb, Patient experienced the following unwanted or unexpected effects: convulsion, tachycardia. During the same period patient was treated with XYLOCAINE (View Xylocaine Review and Xylocaine Label ), LASIX (View Lasix Review and Lasix Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), ALFAROL (View Alfarol Review and Alfarol Label ), SELBEX (View Selbex Review and Selbex Label ), TANKARU (View Tankaru Review and Tankaru Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5223904-9 | Blood Creatine Phosphokinase Increased, Musculoskeletal Stiffness, Myoglobin Blood Increased, Pyrexia
on Jan 19, 2007 Male patient from JAPAN , 61 years of age, weighting 130.1 lb, was diagnosed with epidural anaesthesia, induction of anaesthesia, maintenance of anaesthesia and was treated with Anapeine (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, musculoskeletal stiffness, myoglobin blood increased, pyrexia. Anapeine dosage: . During the same period patient was treated with SEVOFLURANE (1-1.5 %) (View Sevoflurane Review and Sevoflurane Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), OXYGEN (1 Litre/min) (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

5214251-X | Cardiac Arrest, Depressed Level Of Consciousness, Liver Disorder
on Jan 16, 2007 Male patient from JAPAN , 69 years of age, was diagnosed with epidural anaesthesia, sedation and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), depressed level of consciousness, liver disorder. Anapeine dosage: . During the same period patient was treated with FENTANEST (View Fentanest Review and Fentanest Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ALEVIATIN (View Aleviatin Review and Aleviatin Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), ANNACA (View Annaca Review and Annaca Label ), HIRNAMIN (View Hirnamin Review and Hirnamin Label ).

5212991-X | Blood Creatine Phosphokinase Increased, Musculoskeletal Stiffness, Myoglobin Blood Increased, Pyrexia
Patient was taking Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, musculoskeletal stiffness, myoglobin blood increased, pyrexia on Jan 10, 2007 from JAPAN Additional patient health information: Male patient , 61 years of age, weighting 130.1 lb, was diagnosed with epidural anaesthesia, induction of anaesthesia, maintenance of anaesthesia and. Anapeine dosage: . During the same period patient was treated with THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), OXYGEN (1 Litre/min) (View Oxygen Review and Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

5200856-9 | Cauda Equina Syndrome, Neurotoxicity
Adverse event was reported on Dec 26, 2006 by a Female patient taking Anapeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, spinal anaesthesia and. Location: JAPAN , 28 years of age, Patient had the following side effects: cauda equina syndrome, neurotoxicity. During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ).

5191321-6 | Respiratory Failure
on Oct 25, 2006 Male patient from JAPAN , 76 years of age, weighting 93.70 lb, was diagnosed with postoperative analgesia and was treated with Anapeine (View Usage). After Anapeine was administered, patient had the following side effects: respiratory failure. Anapeine dosage: . During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), VECURONIUM BROMIDE (View Vecuronium Bromide Review and Vecuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5165448-9 | Nerve Injury, Post Procedural Complication
on Apr 26, 2005 Female patient from JAPAN , weighting 116.8 lb, was diagnosed with epidural anaesthesia and was treated with Anapeine (View Usage). Patient experienced the following unwanted or unexpected effects: nerve injury, post procedural complication. Anapeine dosage: . During the same period patient was treated with CARBOCAIN (Test Dose) (View Carbocain Review and Carbocain Label ). Patient was hospitalized.

5163911-8 | Cauda Equina Syndrome
Patient was taking Anapeine (View Usage). Patient had the following side effects: cauda equina syndrome on Oct 31, 2006 from JAPAN Additional patient health information: Female patient , 28 years of age, was diagnosed with epidural anaesthesia, spinal anaesthesia and. Anapeine dosage: . During the same period patient was treated with MARCAINE (View Marcaine Review and Marcaine Label ).